Literature DB >> 28487593

Ovarian carcinomatosis in a dog managed with surgery and intraperitoneal, systemic, and intrapleural chemotherapy utilizing indwelling pleural access ports.

Matthew P Best1, Angela E Frimberger1.   

Abstract

A 3-year-old Weimaraner dog was presented with bilateral papillary ovarian carcinoma and abdominal carcinomatosis. Treatment included ovariectomy, intraperitoneal cisplatin, and systemic carboplatin. Pleural carcinomatosis 473 days following surgery was treated with intrapleural cisplatin through indwelling pleural access ports. Euthanasia occurred 1154 days following surgery due to malignant pleural effusion without peritoneal effusion.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28487593      PMCID： PMC5394607     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  26 in total

1.  Ovarian abnormalities in the bitch.

Authors:  C DOW
Journal:  J Comp Pathol       Date:  1960-01       Impact factor: 1.311

2.  High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis.

Authors:  Philippe Esquis; David Consolo; Guy Magnin; Philippe Pointaire; Philippe Moretto; Maria Dolores Ynsa; Jean-Luc Beltramo; Carole Drogoul; Michel Simonet; Laurent Benoit; Patrick Rat; Bruno Chauffert
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

3.  Veterinary Co-operative Oncology Group - Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0.

Authors: 
Journal:  Vet Comp Oncol       Date:  2004-12       Impact factor: 2.613

4.  Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment.

Authors:  G Los; P H Mutsaers; W J Lenglet; G S Baldew; J G McVie
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats.

Authors:  S Tsujitani; A Oka; A Kondo; K Katano; S Oka; H Saito; M Ikeguchi; M Maeta; N Kaibara
Journal:  Oncology       Date:  1999-07       Impact factor: 2.935

6.  Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

Authors:  D S Alberts; P Y Liu; E V Hannigan; R O'Toole; S D Williams; J A Young; E W Franklin; D L Clarke-Pearson; V K Malviya; B DuBeshter
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

7.  Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murine model of peritoneal carcinomatosis.

Authors:  Olivier Facy; François Radais; Sylvain Ladoire; Delphine Delroeux; Hervé Tixier; François Ghiringhelli; Patrick Rat; Bruno Chauffert; Pablo Ortega-Deballon
Journal:  J Exp Clin Cancer Res       Date:  2011-01-07

Review 8.  Pros and cons of intraperitoneal chemotherapy in the treatment of epithelial ovarian cancer.

Authors:  Alain G Zeimet; Daniel Reimer; Alice C Radl; Alexander Reinthaller; Christian Schauer; Edgar Petru; Nicole Concin; Stephan Braun; Christian Marth
Journal:  Anticancer Res       Date:  2009-07       Impact factor: 2.480

9.  A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: a Danish Ovarian Study Group trial (DACOVA).

Authors:  K Bertelsen; A Jakobsen; J Strøyer; K Nielsen; E Sandberg; J E Andersen; S Ahrons; M Nyland; P Hjortkjaer Pedersen; G Larsen
Journal:  Gynecol Oncol       Date:  1993-04       Impact factor: 5.482

10.  Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy.

Authors:  G Los; E M Verdegaal; P H Mutsaers; J G McVie
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
View more
  1 in total

1.  Immunohistochemical features of canine ovarian papillary adenocarcinoma and utility of cell block technique for detecting neoplastic cells in body cavity effusions.

Authors:  Chiaki Kita; James K Chambers; Mika Tanabe; Mitsuhiro Irie; Hiroyuki Yamasaki; Kazuyuki Uchida
Journal:  J Vet Med Sci       Date:  2022-02-01       Impact factor: 1.267
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.